Posted by Michael Wonder on 12 Nov 2020
EMA publishes agenda for 9-12 November CHMP meeting
12 November 2020 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Bevacizumab
- Pertuzumab and trastuzumab
- Netarsudil with latanoprost
- Baloxavir marboxil
Read CHMP agenda
Posted by:
Michael Wonder